A research team has successfully developed the world's first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform.

Using human lung organoids and patient samples, scientists found that during SARS-CoV-2 infection, lung immune cells halt cell growth and drive tissue damage.

According to the Indian Council of Medical Research, around 5,726 people die of this disease annually in India. However, WHO estimates are much higher ...